Category Medicine and Healthcare
Press Release
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
AI Nose accuracy in elderly care improved to 85% with additional Smell ID training AI-friendly healthcare policies to provide tailwinds for commercial rollout Read More
Press Release
Lobe Sciences Appoints Mr. Yong Yao as Chief Financial Officer to Support Strategic Growth
Lobe Sciences Ltd. has appointed Mr. Yong Yao as Chief Financial Officer and Executive Vice President, effective June 1, 2025, to lead the company's financial strategy during its next phase of growth. Mr. Yao brings over 25 years of experience across finance and biotech, with executive roles at companies such as Mountain Valley MD and global firms like Scotiabank and Morgan Stanley. His appointment marks a strategic shift to full-time financial leadership, aligning with Lobe's commitment to regulatory compliance, capital markets readiness, and operational expansion. Read More
Press Release
DEA in Marijuana Crisis: Calls for Termination of Key Officials Amid Constitutional Defiance, Ethical Violations, and Marijuana Bias
The DEA's In-House Forum Takes Another Hit While the Department of Justice has withdrawn its defense of the DEA, the DEA continues to conduct hearings under this unconstitutional framework. Attorney General Pam Bondi wrote in her recent notice to the courts: "The Department has reviewed recent Supreme Court precedent and concluded that the existing structure of DEA's ALJs does not meet constitutional muster. Effective immediately, we will no longer defend this system in litigation and have notified federal courts accordingly." Read More
Press Release
18 Complete Care Facilities Recognized With 2025 AHCA/NCAL Bronze Quality Award
"This award means our facilities have met rigorous, nationally recognized standards for quality and excellence," said Dr. Jessica Israel, Chief Medical and Innovation Officer at Complete Care Management Read More
Press Release
Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform
Company to meet with prospective partners as it accelerates toward IND submission for Telomir-1, with plans to begin human dosing in the first half of 2026 Read More
Press Release
DEA's War on Marijuana Science: How Bureaucratic Clowns Are Blocking Clinical Trials While Spreading Fear Based Fiction
Duane Boise MMJ CEO opined “Now all eyes turn to DEA Administrator-nominee Terrance Cole. Thus far, his public marijuana statements have been evasive, his confirmation answers noncommittal, and his track record steeped in anti-cannabis fearmongering. However, as the DEA boss, he needs to stop the clown show in comparing cannabis to methamphetamine with no clinical basis and distributing memes claiming cannabis lowers sperm count by 50%, despite contradictory evidence”. Read More
Press Release
DrSkin Med Spa Wins Best Med Spa 2025 in Gilbert - Earns Triple Recognition Across Categories
The Only Practice in Gilbert, Arizona, Honored in All Three Categories - Med Spa, Skin Care and Plastic Surgery - DrSkin Celebrates Statewide Support in Just Over Two Years of Innovation in Aesthetic Medicine Read More
Press Release
Elevate X Powers the $600B Longevity Economy With AI-Driven, White-Labeled Clinical Infrastructure
Launching Early Access for Brands, Creators, and Clinics to Deliver Precision Health at Scale Founded by Stanford-trained longevity physician Dr. Hillary Lin, Elevate X enables brands, influencers, and clinicians to deliver precision health programs at scale, without building clinical operations from scratch Read More
Press Release
The Ridge RTC Launches Emerging Adult Program for 18-20 Year Olds at New Hampshire Campus
Located at The Ridge RTC campus in Milton, NH, the Emerging Adult Residential Treatment Program offers nine additional beds and tailored clinical support to an often underserved age group Read More
Press Release
Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints
A unique oral drug candidate that is shown to restore vision and regenerate the retina in an animal model, addressing a major unmet need in ocular therapeutics Read More
Press Release
The National Children's Cancer Society (NCCS) Celebrates 20 Years of the Beyond the Cure Survivorship Program
Since its founding in 2005, this program has remained at the forefront of survivorship care, providing childhood cancer survivors and their families with essential education, resources, and long-term support to help their children not just survive, but thrive. Read More
Press Release
Hospitals in the Line of Fire: Black Book Releases Urgent Federal Policy Risk Report for 2025-2026
14 Underreported Federal Changes That Could Significantly Impact Your Health System: New Data Highlights Key Vulnerabilities and Financial Risks from Trump, RFK Jr., Oz, and the DOGE Agenda Read More
Press Release
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program
The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition. Read More
Press Release
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
Sublingual nano technology delivers caffeine rapidly to the blood stream, bringing its unique disruptive benefits to the Pre-workout market Initial production has commenced with six flavor options Expanded pre-launch consumer testing planned for Q2 2025 Aspire to launch BUZZ BOMB™ at two major upcoming fitness conventions Marketing plan focused on cost-effective multi-channel digital strategy targeting primary influencers, direct response sales and traditional retail sales channels Global pre-workout supplements market size is expected to reach $27.97 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030 Read More
Press Release
DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?
"The Drug Enforcement Administration (DEA) is embroiled in a glaring contradiction: While federally compliant medical cannabis researchers like MMJ BioPharma Cultivation remain paralyzed by bureaucratic delays, U.S. recreational cannabis companies are openly exporting products, intellectual property and money to Europe-flouting federal law with no DEA intervention", stated Duane Boise, CEO MMJ. This double standard exposes a system prioritizing corporate profits over scientific progress and public health, undermining the DEA's mandate under the Controlled Substances Act (CSA). Read More
Press Release
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Diabetes Management Simpler: The New Era of Insulin Therapy" Featuring Modular Medical CEO - Wednesday, May 28, 2025
Meet with Modular Medical CEO Jeb Besser There are 1.9 million individuals with Type 1 Diabetes in the US. 100% of patient population require daily insulin injection. Only 1 out of 3 currently use an insulin pump. Discover how Modular Medical is developing technology to empower the whole diabetes community with MODD1 Register at MODD-Therapy.TribePublic.com Read More
Press Release
World's First AI-Driven Integrative Cancer Care Platform Debuts With Comprehensive Book Series by Dean Silver, M.D. M.D.(H) and Andreas Kazmierczak, MS. Everything You Need to Know to Heal Yourself From Cancer is Now at Your Fingertips.
A pioneering AI-driven platform for integrative cancer care has been developed by AI engineer Andreas Kazmierczak, MS, and meticulously reviewed by renowned integrative oncologist Dean Silver, MD, MD(H). This innovative technology bridges the gap between conventional oncology and holistic medicine, offering patients truly personalized, evidence-based treatment strategies. Read More
Press Release
DEA's Internal Marijuana Resistance: MMJ BioPharma Delays Reflect a Wider Cannabis Rescheduling Crisis
As Former White House Drug Czar Rahul Gupta revealed DEA intentional sabotage, will DEA Administrator Nominee Terrance Cole Address the Marijuana Crisis? Bureaucratic Inaction and Medical Delays Demand Accountability. Read More
Press Release
DEA Defies Supreme Court and Attorney General, Targeting Marijuana Compliant Pharmaceutical Research While Cartels Operate Unchecked
"The irony is glaring," said Boise. "The DEA blocks lawful drug development while cartels profit. The agency is both gatekeeper and roadblock-and now, a constitutional liability." The DEA's own 2025 National Drug Threat Assessment admits that illicit cannabis operations tied to foreign cartels thrive in legalized states, operating under state licenses while DEA policy bureaucrats Thomas Prevoznik and Matthew Strait remains unchecked. Read More
Press Release